These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17998473)

  • 1. Adiponectin, cardiovascular function, and hypertension.
    Wang ZV; Scherer PE
    Hypertension; 2008 Jan; 51(1):8-14. PubMed ID: 17998473
    [No Abstract]   [Full Text] [Related]  

  • 2. Adiponectin and hypertension.
    Ohashi K; Ouchi N; Matsuzawa Y
    Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.
    Barton M; Carmona R; Ortmann J; Krieger JE; Traupe T
    Int J Biochem Cell Biol; 2003 Jun; 35(6):826-37. PubMed ID: 12676169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.
    Jia G; Aroor AR; Hill MA; Sowers JR
    Hypertension; 2018 Sep; 72(3):537-548. PubMed ID: 29987104
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular consequences of sleep apnea].
    Foucher A
    Nephrol Ther; 2007 Dec; 3(7):463-73. PubMed ID: 18048002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade.
    Menne J; Chatzikyrkou C; Haller H
    J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses.
    Pinto YM; Buikema H; van Gilst WH
    Clin Exp Hypertens; 1995 Apr; 17(3):441-68. PubMed ID: 7613522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition and cardiovascular disease.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2499-506. PubMed ID: 17954523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional performance of the cardiovascular system in patients with overweight and obesity].
    Bogdanov AR; Derbeneva SA; Strokova TV; Surkov AG; Kaganov BS
    Vopr Pitan; 2012; 81(1):69-74. PubMed ID: 22642168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity and the cardiovascular system].
    Sniezek-Maciejewska M
    Przegl Lek; 1990; 47(11):784-7. PubMed ID: 2098849
    [No Abstract]   [Full Text] [Related]  

  • 16. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulatory vasoactive substances and pathophysiology of hypertension].
    Matsuoka H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():107-11. PubMed ID: 16895175
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension in obesity.
    Kurukulasuriya LR; Stas S; Lastra G; Manrique C; Sowers JR
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):647-62, ix. PubMed ID: 18775357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adiponectin and cardiovascular diseases].
    Zhang P; Wang NP
    Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):149-52. PubMed ID: 17633232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.